Capricorn Fund Managers’s AbbVie ABBV Stock Holding History

Capricorn Fund Managers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.89M	Hold	27,397	–	–	0.54%	59
2026 Q1	$5.96M	Buy	+27,397	New	+$6.08M	0.93%	36
2025 Q4	–	Sell	-29,535	Closed	-$6.84M	–	83
2025 Q3	$6.84M	Sell	29,535 -1,859	-6%	-$379K	2.3%	16
2025 Q2	$5.83M	Sell	31,394 -2,824	-8%	-$525K	2.75%	15
2025 Q1	$7.17M	Buy	34,218 +208	+0.6%	+$40.4K	3.83%	9
2024 Q4	$5.99M	Sell	34,010 -188	-0.5%	-$34.6K	2.67%	12
2024 Q3	$6.75M	Buy	34,198 +8,751	+34%	+$1.63M	4.55%	6
2024 Q2	$4.36M	Hold	25,447	–	–	3.08%	13
2024 Q1	$4.63M	Hold	25,447	–	–	2.79%	13
2023 Q4	$3.94M	Buy	+25,447	New	+$3.71M	2.17%	17

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capricorn Fund Managers's ABBV Position: Q2 2026 in Review

Capricorn Fund Managers held its AbbVie (ABBV) position steady in Q2 2026 at 27,397 shares worth $6.89M. The position accounts for 0.54% of the portfolio, ranked #59.

Capricorn Fund Managers first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. The position peaked at $7.17M in Q1 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Capricorn Fund Managers held 27,397 shares of AbbVie worth $6.89M as of Q2 2026.
Capricorn Fund Managers left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.54% of Capricorn Fund Managers's portfolio in Q2 2026, its #59 holding.
Capricorn Fund Managers first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
Capricorn Fund Managers's AbbVie position peaked at $7.17M in Q1 2025.
4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capricorn Fund Managers's 13F filing for Q2 2026, filed 24 Jul 2026.